2017
DOI: 10.1097/mca.0000000000000461
|View full text |Cite
|
Sign up to set email alerts
|

Residual thromboxane activity and oxidative stress

Abstract: We found that 11dhTxB2 appears to be a better prognostic marker for mortality as compared with 8-IsoPGF2α, suggesting aspirin resistance itself is a stronger independent determinant of death in CAD patients treated with aspirin.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…This is often used as the gold standard for evaluating the OS level in the body, which has been proven to be one of the independent risk factors of coronary heart disease. [23] Furthermore, the 8-iso-PGF 2α levels are significantly increased in patients with abdominal obesity and metabolic syndrome. [22,24] At 1 week after patients were treated with Roux-en-Y gastric bypass, the plasma level of 8-iso-PGF 2α decreased by more than 50%, while 8-iso-PGF 2α levels decreased by more than 1/3 in subcutaneous adipose tissues.…”
Section: Discussionmentioning
confidence: 99%
“…This is often used as the gold standard for evaluating the OS level in the body, which has been proven to be one of the independent risk factors of coronary heart disease. [23] Furthermore, the 8-iso-PGF 2α levels are significantly increased in patients with abdominal obesity and metabolic syndrome. [22,24] At 1 week after patients were treated with Roux-en-Y gastric bypass, the plasma level of 8-iso-PGF 2α decreased by more than 50%, while 8-iso-PGF 2α levels decreased by more than 1/3 in subcutaneous adipose tissues.…”
Section: Discussionmentioning
confidence: 99%
“…Cardiovascular diseases are the most common cause of death in the world. 1 Coronary artery bypass (CABG) is one of the most common treatments for patients with coronary artery disease. According to the American Heart Association (AHA) in 2015, there are about 400,000 CABGs in the United States per year.…”
Section: Introductionmentioning
confidence: 99%